Announce Date | 03/12/2025 |
EPS Normalized Actual | $5.08 (Beat by $0.11) |
EPS GAAP Actual | $5.08 (Beat by $0.11) |
Revenue Actual | $5.714B |
Revenue Surprise | Beat by $5714M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Nov 2029 | 30.96 | 11.27 | 30.38408 | 31.51098 | 1 |
Dec 2028 | 28.63 | 12.19 | 28.22481 | 29.3509 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | 4.15 | 4.15 | 5.714B | 9.31% | 5714M |
FQ4 2024 (Nov 2024) | 3.82 | 3.82 | 5.606B | 9.95% | 5606M |
FQ3 2024 (Aug 2024) | 3.78 | 3.78 | 5.408B | 9.58% | 5408M |
FQ2 2024 (May 2024) | 3.5 | 3.5 | 5.309B | 9.29% | 5309M |
FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 5.182B | 10.17% | 5182M |
FQ4 2023 (Nov 2023) | 3.26 | 3.26 | 5.048B | 100% | 5048M |
FQ3 2023 (Aug 2023) | 3.07 | 3.07 | 4.89B | 9.35% | 4890M |
FQ2 2023 (May 2023) | 2.83 | 2.83 | 4.816B | 100% | 4816M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Nov 2027) | 6.69002 | -- | 6.64679 | 6.82202 | 14 |
FQ3 2027 (Aug 2027) | 6.47546 | -- | 6.43531 | 6.60495 | 14 |
FQ2 2027 (May 2027) | 6.23366 | -- | 6.19501 | 6.35832 | 14 |
FQ1 2027 (Feb 2027) | 6.23893 | -- | 6.21035 | 6.29386 | 13 |
FQ4 2026 (Nov 2026) | 5.98212 | -- | 5.94346 | 6.10015 | 27 |
FQ3 2026 (Aug 2026) | 5.7955 | -- | 5.75956 | 5.9114 | 26 |
FQ2 2026 (May 2026) | 5.787 | -- | 5.73657 | 5.87369 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Nov 2027) | 7.28B | -- | 7.24B | 7.39B | 20 |
FQ3 2027 (Aug 2027) | 7.06B | -- | 7.02B | 7.17B | 13 |
FQ2 2027 (May 2027) | 6.95B | -- | 6.92B | 7.06B | 13 |
FQ1 2027 (Feb 2027) | 6.81B | -- | 6.78B | 6.85B | 8 |
FQ4 2026 (Nov 2026) | 6.69B | -- | 6.66B | 6.79B | 13 |
FQ3 2026 (Aug 2026) | 6.47B | -- | 6.44B | 6.57B | 13 |
FQ2 2026 (May 2026) | 6.57B | -- | 6.52B | 6.64B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 4.15 | 4.15 | 100% | |
FQ4 2024 (Nov 2024) | 3.82 | 3.82 | 100% | |
FQ3 2024 (Aug 2024) | 3.78 | 3.78 | 100% | |
FQ2 2024 (May 2024) | 3.5 | 3.5 | 100% | |
FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 100% | |
FQ4 2023 (Nov 2023) | 3.26 | 3.26 | 100% | |
FQ3 2023 (Aug 2023) | 3.07 | 3.07 | 100% | |
FQ2 2023 (May 2023) | 2.83 | 2.83 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0B | $5.71B | $5714M | 100% |
FQ4 2024 (Nov 2024) | $0B | $5.61B | $5606M | 100% |
FQ3 2024 (Aug 2024) | $0B | $5.41B | $5408M | 100% |
FQ2 2024 (May 2024) | $0B | $5.31B | $5309M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.18B | $5182M | 100% |
FQ4 2023 (Nov 2023) | $0B | $5.05B | $5048M | 100% |
FQ3 2023 (Aug 2023) | $0B | $4.89B | $4890M | 100% |
FQ2 2023 (May 2023) | $0B | $4.82B | $4816M | 100% |